Last reviewed · How we verify
NCT06374862: RACHIMOB
Effects of Specific Thoracic Spine Mobilizations on Muscle Activity in a Healthy Volunteer Population
NA trial testing mobilization in Musculoskeletal Manipulations in 156 participants. Completed in 16 February 2026.
28 October 2025
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 156 |
| Start date | 28 March 2024 |
| Primary completion | 28 October 2025 |
| Estimated completion | 16 February 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- mobilization
- no effect
Conditions studied
- Musculoskeletal Manipulations — all drugs for Musculoskeletal Manipulations →
- Range of Motion — all drugs for Range of Motion →
- Muscle Strength — all drugs for Muscle Strength →
- Peripheral Joints in Upper Quarters — all drugs for Peripheral Joints in Upper Quarters →
Sponsor
Centre Hospitalier Universitaire, Amiens
Who can join
Adults 18 to 65, any sex, with Musculoskeletal Manipulations or Range of Motion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the investigators will examine the effect of manual therapy on the thoracic spine and its impact on the muscular strength gain of the thoracic extensors. Treatment with manual therapy, as described by Maitland, consists of a specific mobilization of the thoracic spine in the postero-anterior direction on the transverse and spiny processes of the thoracic vertebrae. To ensure the relevance of the measures, and to better control the occurrence of biases inherent to the practice of manual therapy, the investigators constituted three distinct groups: an intervention group, a control group and a group without intervention. In short, this methodology will allow us to explore in detail the effects of specific spinal mobilization on motor control, while taking into account placebo response elements and natural variations in the results
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06374862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mobilization
Trials testing the same drug.
- NCT06886334 — Flexion-Distraction Technique · Phase 1, PHASE2 · not yet recruiting
- NCT06763679 — Compare the Effect of Spencer Technique With and Without AC Mobilization for FS Pathients · NA · recruiting
- NCT06456944 — Effect of Selected Rehabilitation Program in Patients With Plantar Fasciitis · NA · completed
- NCT06440928 — Results of Cervical Segmental Mobilization in Patients With Chronic Lateral Epicondylitis · NA · recruiting
- NCT06407466 — The Effect of Soft Tissue Mobilization and Kinesio Taping Applied to Athletics Athletes on Sports Performance · NA · completed
Other Centre Hospitalier Universitaire, Amiens trials
Trials by the same sponsor.
- NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
- NCT07071662 — Induction of Labor in Breech Presentation · completed
- NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
- NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
- NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06374862 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
- Last refreshed: 31 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06374862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing